Innovative Clinical Research Solutions
- Since 1991 -
Full-Service, Dedicated, Data Driven – from “Thought to Finish”, Every Trial, Every Time.
Moleculin Announces Positive Trial Data with 100% Safe Delivery of p-STAT3 Inhibitor and Efficacy in Majority of Patients Preliminary results from phase 1 clinical trial of WP1220 for treatment of cutaneous T-cell lymphoma (“CTCL”); supports phase 2 study. “For years, p-STAT3 (the activated form of STAT3) has been considered an ‘undruggable’
Meet With Us!
- Contact Ronny Schnel (310-619-6691 PT USA) for a Video Teleconference
- SWOG Fall 2020 Meeting – September 23-26 – Chicago, IL
- Site Solutions Summit (Society for Clinical Research Sites) – October 6-22 (Virtual Event)
- IASLC 2020 North America Conference on Lung Cancer – October 16-17 (Virtual Event)
- American Medical Device Summit 2020 – October 13-15 (Virtual Event)
- ID Week 2020 – Starts October 22 (Virtual Event)
- CNS Summit – October 29-November 1 (Virtual Event)